Opinion
7mOpinion
DR. MAKARY, DR OZ: People talk about lowering health care costs, but the Trump administration is doing it
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback